Clinical trial
Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency…
NCT00028236 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00028236 |
|---|---|
| Title | Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) |
| Official title | Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Severe Combined Immunodeficiency |
| Intervention type | Drug |
| Interventions | Gene-Transduced Autologous CD34+ Stem Cells |
| Enrollment | 3 |
| Start date | Dec 10, 2001 |
| Primary completion | Jul 25, 2011 |
| Completion | Jul 25, 2011 |
| First posted | Dec 18, 2001 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: